Copy
PrePex Newsletter #35, May 2017
View this email in your browser
Circ MedTech completed a Clinical Field Study improving the PrePex Procedure
The report was submitted for the review of the World Health Organization 

 
Following the September 2016 - WHO Guidelines regarding Male Circumcision and Tetanus Infection, Circ MedTech has improved the PrePex Procedure to facilitate use of the device with equal Tetanus mitigation to that of Surgical Circumcision.
 
The improved technique enables Removal of the Foreskin shortly after the device placement (D0FRP) while maintaining the PrePex benefits.

Hence, we invite you to join the following Webinar:

PrePex™ Day-Zero Foreskin Removal Procedure (D0FRP)
Results from a Clinical Field Study

Presented by:
Dr. David Linyama - Study Principal Investigator

Tuesday, May 9th, 2017
09:00 – 10:00 EST / 15:00 – 16:00 CAT


Please join us on May 9th  for an update from Dr. David Linyama* on results of the PrePex D0FRP Clinical Field Study. 
 
The Study, conducted in two settings in Zambia, was designed to validate the safety and efficacy of the PrePex Day-Zero Foreskin Removal Procedure. Dr. Linyama will share safety results, procedure characteristics and other important findings of the Study. Following a presentation of the Clinical Results, Dr. Linyama will answer questions regarding his team’s experience with the PrePex D0FRP.  The webinar will be moderated by Dr. Jackson Okuku**

For your convenience, the webinar does not require pre-registration.

To join, simply log in 10 minutes before the webinar is about to start in this link:  
https://prepex.webex.com/prepex/onstage/g.php?MTID=e93148a0778532cb7e89add5fc27b5d90
*Dr. David Linyama, MD is Consultant General Surgeon at the Choma General Hospital in Choma, Zambia; the Southern Province MC leader, and responsible for ensuring safe quality MC services throughout the province. Dr. Linyama served as Clinical head of the Male Circumcision Program for the Centre for Infectious Disease Research in Zambia (CIDRZ), and for Early Infant Male Circumcision (EIMC), which is device based. Through this program, he has established EIMC services. He has also participated as Co-investigator in the study: Randomized Controlled Trial of the ShangRing for Adult Medical Male Circumcision.
**Dr. Jackson Okuku, MD, MPH, MSs, is a Public Health Specialist with many years of exposure and experience in the design, implementation and management of VMMC programs in Eastern and Southern Africa regions — especially in Zambia. In Zambia, he was once National Coordinator for the fhi360 VMMC program, served as Senior Technical Adviser for Jhpiego's VMMC projects, and Chairperson of the Service Delivery Subcommittee of the National VMMC Technical Working Group.
Thank you for following our updates! 
The PrePex Team  
Share
Tweet
Forward
Share
Copyright © 2017 Circ MedTech Ltd.
Contact us at: info@prepex.com 
Want to change how you receive these emails? 
You can update your preferences or unsubscribe from this list